CA2017956A1 - Use of retinoids - Google Patents

Use of retinoids

Info

Publication number
CA2017956A1
CA2017956A1 CA002017956A CA2017956A CA2017956A1 CA 2017956 A1 CA2017956 A1 CA 2017956A1 CA 002017956 A CA002017956 A CA 002017956A CA 2017956 A CA2017956 A CA 2017956A CA 2017956 A1 CA2017956 A1 CA 2017956A1
Authority
CA
Canada
Prior art keywords
disorders
naphthyl
phenol
propenyl
tetramethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002017956A
Other languages
English (en)
French (fr)
Inventor
Werner Bollag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2017956A1 publication Critical patent/CA2017956A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002017956A 1989-07-06 1990-05-31 Use of retinoids Abandoned CA2017956A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2520/89 1989-07-06
CH252089 1989-07-06

Publications (1)

Publication Number Publication Date
CA2017956A1 true CA2017956A1 (en) 1991-01-06

Family

ID=4235631

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002017956A Abandoned CA2017956A1 (en) 1989-07-06 1990-05-31 Use of retinoids

Country Status (9)

Country Link
EP (1) EP0407788A3 (enrdf_load_stackoverflow)
JP (1) JPH0344320A (enrdf_load_stackoverflow)
KR (1) KR910002434A (enrdf_load_stackoverflow)
AU (1) AU5861690A (enrdf_load_stackoverflow)
CA (1) CA2017956A1 (enrdf_load_stackoverflow)
HU (1) HUT54298A (enrdf_load_stackoverflow)
IE (1) IE902438A1 (enrdf_load_stackoverflow)
IL (1) IL94942A0 (enrdf_load_stackoverflow)
ZA (1) ZA905125B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60202500A (ja) * 1984-03-27 1985-10-12 松下電器産業株式会社 音素認識方法
ES2083891B1 (es) * 1991-04-24 1997-01-16 Univ Valencia Estudi General Procedimiento de obtencion de derivados del 2-(1-propenil) fenol.
ATE304350T1 (de) * 1997-05-14 2005-09-15 Atherogenics Inc Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3602473A1 (de) * 1986-01-28 1987-07-30 Basf Ag Vinylphenolderivate, ihre herstellung und verwendung
ZW6587A1 (en) * 1986-05-13 1987-12-02 Hoffmann La Roche Tetrahydro naphthanline derivatives

Also Published As

Publication number Publication date
ZA905125B (en) 1991-03-27
AU5861690A (en) 1991-01-10
IL94942A0 (en) 1991-06-10
KR910002434A (ko) 1991-02-25
HUT54298A (en) 1991-02-28
JPH0344320A (ja) 1991-02-26
EP0407788A2 (de) 1991-01-16
EP0407788A3 (en) 1991-05-15
HU904053D0 (enrdf_load_stackoverflow) 1990-12-28
IE902438A1 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
JP3759162B2 (ja) ピートから誘導した生物活性生成物、ならびにこの生物活性生成物を含有する製剤組成物および化粧品組成物
US7229650B2 (en) Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
RU2000107124A (ru) Лечение опосредуемых клеткой иммунных болезней
EP0138216A2 (en) Sustained-release IFN preparation for parenteral administration
KR100366200B1 (ko) L-카르니틴염과이를함유한피부질환치료용화장품조성물및약제조성물
JPH0779661B2 (ja) 食品組成物
JP3098544B2 (ja) サイトカイン活性増強剤およびサイトカインの働きが低下した疾病の治療剤
CA2017956A1 (en) Use of retinoids
CA2016985C (en) Dehydrocholecalciferol derivatives
JPS60120995A (ja) 新規アミノ酸誘導体の製法
Hoffer et al. Vitamin E decreases erythrocyte fragility after whole-body irradiation
US4416898A (en) Therapeutic uses of methionine
JPH06305955A (ja) キノン系細胞分化誘導剤
JP2005082806A (ja) 新規なオキナワモズク由来フコイダン及び免疫賦活剤
CA1268124A (en) Use of a retinoid
JPH06239757A (ja) 抗アレルギー剤
JPH07258091A (ja) アトピー性皮膚炎治療剤
US3574853A (en) Composition and method of reducing serum cholesterol with thiobiscresols
CA2124852A1 (en) Use of a known chemical compound for the production of a pharmaceutical composition for topical application
JPH0426624A (ja) 慢性腎不全改善剤
Ohmann et al. Effect of dexamethasone on bovine leukocyte functions and bovine herpesvirus type-1 replication
JP4945869B2 (ja) 免疫賦活剤
WO2023155158A1 (en) Use of mangosteen fruit shell extract in the preparation of a medicament for promoting wound healing in diabetes
EP3878840A1 (en) Crystalline forms of salts of n1,n12-di (all-trans-retinoyl)spermine, processes for their production, and pharmaceutical compositions thereof
EP0754447A1 (en) Skin-cosmetic composition

Legal Events

Date Code Title Description
FZDE Discontinued